Is a complete GELS research report available?

No complete published report is available for Gelteq Limited (GELS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Gelteq Limited (GELS)

NASDAQ: GELS · USD

$0.47

+0.01 (+1.7%)· Recorded snapshot

Market cap	5.2M
Revenue (ttm)	314.7K
Net income (ttm)	-4.7M
EPS (ttm)	-$0.47
Shares out	11.2M
Volume	11,747
Beta	-0.39

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 314.7K
Net income (ttm): -4.7M
EPS (ttm): -$0.47
Market cap: 5.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0001920092
Company name	Gelteq Limited
Country	Australia
Country code	US
Earnings date	2026-11-17
Earnings time	bmo
Employees	8
Employees change	5
Employees growth	166.67%
Enterprise value	$8.6M
Exchange	NASDAQ
Financial currency	AUD
Financial report date	2025-12-31
First seen	2026-05-09
Fiscal year end	June
Founded	2018
Industry	Drug Manufacturers - Specialty & Generic
IPO date	2024-10-29
Is primary listing	Yes
Is SPAC	No
ISIN number	AU0000218109
Last 10-K release date	2025-11-17
Last earnings date	2026-06-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$5.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-17
Options	No
Price	$0.47
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GELS
Website	https://www.gelteq.com

Metric

Value

Amount currency

USD

CIK code

0001920092

Company name

Gelteq Limited

Country

Australia

Country code

Earnings date

2026-11-17

Earnings time

bmo

Employees

Employees change

Employees growth

166.67%

Enterprise value

$8.6M

Exchange

NASDAQ

Financial currency

AUD

Financial report date

2025-12-31

First seen

2026-05-09

Fiscal year end

June

Founded

2018

Industry

Drug Manufacturers - Specialty & Generic

IPO date

2024-10-29

Is primary listing

Yes

Is SPAC

ISIN number

AU0000218109

Last 10-K release date

2025-11-17

Last earnings date

2026-06-30

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$5.2M

Market cap category

Nano-Cap

Next earnings date

2026-11-17

Options

Price

$0.47

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

GELS

Website

https://www.gelteq.com

Metric	Value
Earnings yield	-100.6%
EV/Sales	27.56x
FCF / EV yield	-24.41%
FCF yield	-40.2%
Industry forward P/E	13.86x
Industry P/E	173.47x
P/B ratio	0.54x
P/S ratio	16.74x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-100.6%

EV/Sales

27.56x

FCF / EV yield

-24.41%

FCF yield

-40.2%

Industry forward P/E

13.86x

Industry P/E

173.47x

P/B ratio

0.54x

P/S ratio

16.74x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	75.54%
Operating margin	-1,351.12%
Pretax margin	-1,501.31%
Profit per employee	$-590,582
Revenue per employee	$39,338
ROA	-17.61%
ROA (5Y)	-8.3%
ROCE	-44.72%
ROE	-42.93%
ROE (5Y)	-20.44%
ROIC	-18.97%

Metric

Value

Gross margin

75.54%

Operating margin

-1,351.12%

Pretax margin

-1,501.31%

Profit per employee

$-590,582

Revenue per employee

$39,338

ROA

-17.61%

ROA (5Y)

-8.3%

ROCE

-44.72%

ROE

-42.93%

ROE (5Y)

-20.44%

ROIC

-18.97%

Metric	Value
EPS growth years	0
Gross profit growth	3,060.15%
Gross profit growth (Q)	48.92%
Gross profit growth 3Y	30.63%
Net income growth years	0
Revenue growth	153.17%
Revenue growth (Q)	48.92%
Revenue growth (QoQ)	0%
Revenue growth 3Y	43.44%
Revenue growth years	0

Metric

Value

EPS growth years

Gross profit growth

3,060.15%

Gross profit growth (Q)

48.92%

Gross profit growth 3Y

30.63%

Net income growth years

Revenue growth

153.17%

Revenue growth (Q)

48.92%

Revenue growth (QoQ)

Revenue growth 3Y

43.44%

Revenue growth years

Metric	Value
Capital expenditures	$0
Depreciation and amortization	$870,555
EBIT	$-4.3M
EBITDA	$-3.4M
EPS	$-0.47
FCF per share	$-0.19
Financing cash flow	$319,604
Free cash flow	$-2.1M
Gross profit	$237,728
Investing cash flow	$-316,047
Net borrowing	$-175,519
Net cash flow	$-2.1M
Net income	$-4.7M
Operating income	$-4.3M
Revenue	$314,701

Metric

Value

Capital expenditures

Depreciation and amortization

$870,555

EBIT

$-4.3M

EBITDA

$-3.4M

EPS

$-0.47

FCF per share

$-0.19

Financing cash flow

$319,604

Free cash flow

$-2.1M

Gross profit

$237,728

Investing cash flow

$-316,047

Net borrowing

$-175,519

Net cash flow

$-2.1M

Net income

$-4.7M

Operating income

$-4.3M

Revenue

$314,701

Metric	Value
Altman Z-Score	-0.54
Book value per share	$0.85
Debt / equity	0.36
Interest coverage	-2.93
Long-term assets	$13M
Long-term liabilities	$-179,292
Net cash (debt)	$-3.4M
Net cash / market cap	-64.64%
Net debt / equity	0.36
Piotroski F-Score	2
Property, plant and equipment	$9,654
Shareholders' equity	$9.5M
Tangible book value	$-3.4M
Tangible book value per share	$-0.30
Total assets	$13.4M
Total cash	$6,236
Total debt	$3.4M
Total liabilities	$4M
WACC	14.48%

Metric

Value

Altman Z-Score

-0.54

Book value per share

$0.85

Debt / equity

0.36

Interest coverage

-2.93

Long-term assets

$13M

Long-term liabilities

$-179,292

Net cash (debt)

$-3.4M

Net cash / market cap

-64.64%

Net debt / equity

0.36

Piotroski F-Score

Property, plant and equipment

$9,654

Shareholders' equity

$9.5M

Tangible book value

$-3.4M

Tangible book value per share

$-0.30

Total assets

$13.4M

Total cash

$6,236

Total debt

$3.4M

Total liabilities

$4M

WACC

14.48%

Metric	Value
Asset turnover	0.02
Current assets	$375,027
Current liabilities	$4.1M
Current ratio	0.09
Inventory turnover	3.63
Net working capital	$-164,999
Quick ratio	0.07
Working capital	$-3.6M
Working capital turnover	-0.09

Metric

Value

Asset turnover

0.02

Current assets

$375,027

Current liabilities

$4.1M

Current ratio

0.09

Inventory turnover

3.63

Net working capital

$-164,999

Quick ratio

0.07

Working capital

$-3.6M

Working capital turnover

-0.09

Metric	Value
Buyback yield / dilution	-21.92%
Dividend yield	0%
Shareholder yield	-21.92%

Metric

Value

Buyback yield / dilution

-21.92%

Dividend yield

Shareholder yield

-21.92%

Metric	Value
150-day SMA	$0.60
1D price change	1.72%
1M price change	-14.62%
1M total return	-14.62%
1W price change	6%
1W total return	6%
1Y price change	-61.47%
1Y return CAGR	-61.5%
1Y total return	-61.47%
20-day SMA	$0.48
200-day SMA	$0.66
3M price change	-29.47%
3M total return	-29.47%
50-day SMA	$0.56
50-day SMA vs 200-day SMA	50under200
52-week high	$2.01
52-week high date	2026-06-11
52-week low	$0.39
52-week low date	2026-05-20
6M price change	-32.92%
6M total return	-32.92%
All-time high	$5.50
All-time high date	2024-12-10
All-time low	$0.39
All-time low date	2026-05-20
Average true range (ATR)	$0.05
Average volume	93.4K
Beta (1Y)	1.43
Beta (2Y)	2.61
Beta (5Y)	-0.39
Change from 52-week high	-76.81%
Change from 52-week low	20.47%
Change from all-time high	-91.52%
Change from all-time low	20.47%
Change from open	1%
Day's gap	0.72%
Dollar volume	$5,476
High price	$0.47
Low price	$0.46
Monthly RSI	31.33
Open price	$0.46
Position in 52-week range	100%
Premarket change	-1.81%
Premarket close	$0.46
Premarket price	$0.45
Premarket volume	205
Previous close	$0.46
Price vs 150-day SMA	-22.87%
Price vs 20-day SMA	-3.58%
Price vs 200-day SMA	-29.86%
Price vs 50-day SMA	-17.4%
Relative volume	0.13
Return from IPO open	-88.23%
Return from IPO price	-88.23%
RSI	43.69
Sharpe ratio	0.24
Sortino ratio	0.75
Volume	11.7K
Weekly RSI	43.09
YTD price change	-41.73%
YTD total return	-41.73%

Metric

Value

150-day SMA

$0.60

1D price change

1.72%

1M price change

-14.62%

1M total return

-14.62%

1W price change

1W total return

1Y price change

-61.47%

1Y return CAGR

-61.5%

1Y total return

-61.47%

20-day SMA

$0.48

200-day SMA

$0.66

3M price change

-29.47%

3M total return

-29.47%

50-day SMA

$0.56

50-day SMA vs 200-day SMA

50under200

52-week high

$2.01

52-week high date

2026-06-11

52-week low

$0.39

52-week low date

2026-05-20

6M price change

-32.92%

6M total return

-32.92%

All-time high

$5.50

All-time high date

2024-12-10

All-time low

$0.39

All-time low date

2026-05-20

Average true range (ATR)

$0.05

Average volume

93.4K

Beta (1Y)

1.43

Beta (2Y)

2.61

Beta (5Y)

-0.39

Change from 52-week high

-76.81%

Change from 52-week low

20.47%

Change from all-time high

-91.52%

Change from all-time low

20.47%

Change from open

Day's gap

0.72%

Dollar volume

$5,476

High price

$0.47

Low price

$0.46

Monthly RSI

31.33

Open price

$0.46

Position in 52-week range

100%

Premarket change

-1.81%

Premarket close

$0.46

Premarket price

$0.45

Premarket volume

205

Previous close

$0.46

Price vs 150-day SMA

-22.87%

Price vs 20-day SMA

-3.58%

Price vs 200-day SMA

-29.86%

Price vs 50-day SMA

-17.4%

Relative volume

0.13

Return from IPO open

-88.23%

Return from IPO price

-88.23%

RSI

43.69

Sharpe ratio

0.24

Sortino ratio

0.75

Volume

11.7K

Weekly RSI

43.09

YTD price change

-41.73%

YTD total return

-41.73%

Metric	Value
Float	5.2M
Float percentage	46.06%
Shares change (QoQ)	0%
Shares change (YoY)	21.92%
Shares held by insiders	29.64%
Shares held by institutions	2.55%
Shares outstanding	11.2M
Short % of float	10.11%
Short % of shares	4.66%
Short ratio	0.1 days

Metric

Value

Float

5.2M

Float percentage

46.06%

Shares change (QoQ)

Shares change (YoY)

21.92%

Shares held by insiders

29.64%

Shares held by institutions

2.55%

Shares outstanding

11.2M

Short % of float

10.11%

Short % of shares

4.66%

Short ratio

0.1 days

Gelteq Limited (GELS)

Price

Financial snapshot

Fair-value bridge

Latest news · GELS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GELS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GELS

Frequently asked questions